MARA Holdings
MARA
MicroStrategy
MSTR
Tesla
TSLA
Coinbase
COIN
NVIDIA
NVDA
US Stock MarketDetailed Quotes
GALT Galectin Therapeutics
- 1.160
- -0.010-0.85%
Close Jan 3 16:00 ET
- 1.160
- 0.0000.00%
Post 20:01 ET
72.80MMarket Cap-1.59P/E (TTM)
1.230High1.140Low517.11KVolume1.160Open1.170Pre Close608.56KTurnover1.18%Turnover RatioLossP/E (Static)62.76MShares4.26852wk High-0.77P/B50.93MFloat Cap0.72652wk Low--Dividend TTM43.90MShs Float38.280Historical High--Div YieldTTM7.69%Amplitude0.300Historical Low1.176Avg Price1Lot Size
Galectin Therapeutics News
Galectin Therapeutics | 8-K: Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2024 and Provides Business Update
Galectin Therapeutics | 10-Q: Q3 2024 Earnings Report
Galectin Therapeutics | 8-K: Galectin Therapeutics Reports Financial Results for the Quarter Ended June 30, 2024 and Provides Business Update
Galectin Therapeutics | 10-Q: Q2 2024 Earnings Report
Galectin Therapeutics | 8-K: Galectin Therapeutics Reports Financial Results for the Quarter Ended March 31, 2024 and Provides Business Update
Galectin Therapeutics | 10-Q: Q1 2024 Earnings Report
Galectin Therapeutics | 10-K: FY2023 Annual Report
Galectin Therapeutics | 8-K/A: Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2023 and Provides Business Update
Galectin Therapeutics | 8-K: Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2023 and Provides Business Update
Galectin Therapeutics | 10-Q: Q3 2023 Earnings Report
Galectin Therapeutics | 8-K: Galectin Therapeutics Reports Financial Results for the Quarter Ended June 30, 2023 and Provides Business Update
Galectin Therapeutics | 10-Q: Q2 2023 Earnings Report
Galectin Therapeutics | 8-K: Galectin Therapeutics Reports Financial Results for the Quarter Ended March 31, 2023 and Provides Business Update
Galectin Therapeutics | 10-Q: Q1 2023 Earnings Report
Galectin Therapeutics | 10-K: FY2022 Annual Report
Galectin Therapeutics | 8-K: Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2022 and Provides Business Update
Galectin Therapeutics | 10-Q: Q3 2022 Earnings Report
Galectin Therapeutics | 8-K: Galectin Therapeutics Reports Financial Results for the Quarter Ended June 30, 2022 and Provides Business Update
Galectin Therapeutics | 10-Q: Q2 2022 Earnings Report
Galectin Therapeutics | 8-K: Galectin Therapeutics Reports Financial Results for the Quarter Ended March 31, 2022 and Provides Business Update
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.